🇺🇸 FDA
Patent

US 8445694

Hydrazonopyrazole derivatives and their use as therapeutics

granted A61KA61K31/415A61K31/4155

Quick answer

US patent 8445694 (Hydrazonopyrazole derivatives and their use as therapeutics) held by Dermira (Canada), Inc. expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Dermira (Canada), Inc.
Grant date
Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/415, A61K31/4155, A61K31/655, A61P